-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Boundless Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2023 to Q2 2025.
- Boundless Bio, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2025 was $1.39M, a 42.6% decline year-over-year.
- Boundless Bio, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2025 was $7.01M, a 4.04% decline year-over-year.
- Boundless Bio, Inc. annual Nonoperating Income (Expense) for 2024 was $7.9M, a 47.4% increase from 2023.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)